跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AT-1000
首页
药物
AT-1000
AT-1000
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF ATOPIC DERMATITIS CONTAINING IL-31 ANTAGONIST AS ACTIVE INGREDIENT
EP 4650370 A3
申请人: CHUGAI PHARMACEUTICAL CO LTD
优先权: 2015
CN
EP
US
WO
11 件公开
FUNCTIONALISED CHROMATOGRAPHY MEDIUM COMPRISING POLYMER NANOFIBRES AND PROCESS OF PREPARATION THEREOF
EP 3484613 A1
申请人: PURIDIFY LTD
优先权: 2016
CN
EP
US
7 件公开
INSULIN FORMULATIONS AND METHODS OF USING SAME IN PRETERM INFANTS
EP 4322989 A4
申请人: ELGAN PHARMA LTD
优先权: 2021
EP
US
WO
7 件公开
Modified bio-related substance, process for producing the same, and intermediate
US 7524875 B2
申请人: NOF CORP
优先权: 2002
US
7 件公开
A METHOD OF PREPARING A SHAPED CATALYST, THE CATALYST, AND USE OF THE CATALYST
EP 1796834 A2
申请人: SHELL OIL CO
优先权: 2004
CN
EP
US
WO
5 件公开
Reduced dose intravenous acetaminophen
US 9399012 B2
申请人: ROYAL MIKE ALLAN
优先权: 2008
US
5 件公开
RINSE-OFF SKIN CARE COMPOSITIONS CONTAINING CELLULOSIC MATERIALS
US 2014134218 A1
申请人: CONSUMER COMPANIES INC JOHNSON & JOHNSON
优先权: 2013
US
5 件公开
GOLD NANOPARTICLE COMPOSITION, DNA CHIP, NEAR INFRARED ABSORBENT, DRUG CARRIER FOR DRUG DELIVERY SYSTEM (DDS), COLORING AGENT, BIOSENSOR, COSMETIC, COMPOSITION FOR IN VIVO DIAGNOSIS AND COMPOSITION FOR THERAPEUTIC USE
US 2010285994 A1
申请人: SHIGA UNIVERSITY OF MEDICAL SC
优先权: 2007
CN
EP
US
WO
4 件公开
Modafinil oral lyophilizate
US 2006024370 A1
申请人: CEPHALON FRANCE
优先权: 2005
CN
US
4 件公开
EP 1621186 A1
申请人: CEPHALON FRANCE
优先权: 2004
EP
OPHTHALMIC SOLUTIONS DISPLAYING IMPROVED EFFICACY
US 2009239775 A1
申请人: COLLINS GARY L
优先权: 2009
CN
US
4 件公开
第 1 / 10 页
上一页
下一页
药物
反馈